| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
22,089
|
24,061
|
17,195
|
19,879
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
22,089
|
24,061
|
17,195
|
19,879
| |
|
Operating Expenses |
|
Research Development | 17,865 | 17,326 | 13,634 | 15,393 |
|
Selling General and Administrative | 4,135 | 3,482 | 4,188 | 3,650 |
|
Non Recurring |
-
|
-
| 7,402 |
-
|
|
Others | 1,905 | 1,969 | 1,938 | 1,941 |
|
|
|
Total Operating Expenses |
-
|
-
| 27,162 |
-
| | | |
Operating Income or Loss
|
(1,816)
|
1,284
|
(9,391)
|
(405)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (1,543) | 103 | 2,728 | 715 |
|
Earnings Before Interest And Taxes | (3,359) | 1,387 | (7,239) | (390) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (3,359) | 1,387 | (7,239) | (390) |
|
Income Tax Expense | (3,847) | (3,140) | (5,479) | (1,630) |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 488 | 4,527 | (1,760) | 1,240 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
488
|
4,527
|
(1,760)
|
1,240
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
488
|
4,527
|
(1,760)
|
1,240
|
|
0.04(0.77%) 12:45PM EDT - Nasdaq Real Time Price